17-1709861-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001164407.2(TLCD2):c.202G>A(p.Ala68Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000262 in 1,526,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001164407.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151868Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000756 AC: 1AN: 132278Hom.: 0 AF XY: 0.0000139 AC XY: 1AN XY: 72014
GnomAD4 exome AF: 0.00000145 AC: 2AN: 1374686Hom.: 0 Cov.: 34 AF XY: 0.00000295 AC XY: 2AN XY: 678662
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151868Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74170
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.202G>A (p.A68T) alteration is located in exon 2 (coding exon 2) of the TLCD2 gene. This alteration results from a G to A substitution at nucleotide position 202, causing the alanine (A) at amino acid position 68 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at